FDA Bulk Actives GMP Guidance Returned To Draft By ICH Foray Into GMPs
Executive Summary
FDA's near-final guidance on good manufacturing practices for active pharmaceutical ingredients will return to the draft stage as a result of the International Conference on Harmonization's decision to begin work immediately on its own guidance on the subject.